Approach to relapsed CLL including Richter Transformation

被引：2
|
作者：
Seymour, John F. [1 ,2 ]
机构：
[1] Univ Melbourne, Royal Melbourne Hosp, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[2] Peter MacCallum Canc Ctr, Dept Haematol, 305 Grattan St, Melbourne, VIC 3000, Australia
来源：
HEMATOLOGICAL ONCOLOGY | 2023年 / 41卷
关键词：
acalabrutinib; chronic lymphocytic leukemia; ibrutinib; relapse; Richter transformation; treatment sequencing; Venetoclax; zanubrutinib; CHRONIC LYMPHOCYTIC-LEUKEMIA; VENETOCLAX PLUS RITUXIMAB; OPEN-LABEL; MUTATIONS; MECHANISMS; IDELALISIB; RESISTANCE; SURVIVAL; EFFICACY; THERAPY;
D O I：
10.1002/hon.3146
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：136 / 143
页数：8
相关论文
共 50 条
  • [41] BET proteolysis targeted chimera-based therapy of novel models of Richter Transformation-diffuse large B-cell lymphoma
    Fiskus, Warren
    Mill, Christopher P.
    Perera, Dimuthu
    Birdwell, Christine
    Deng, Qing
    Yang, Haopeng
    Lara, Bernardo H.
    Jain, Nitin
    Burger, Jan
    Ferrajoli, Alessandra
    Davis, John A.
    Saenz, Dyana T.
    Jin, Wendy
    Coarfa, Cristian
    Crews, Craig M.
    Green, Michael R.
    Khoury, Joseph D.
    Bhalla, Kapil N.
    LEUKEMIA, 2021, 35 (09) : 2621 - 2634
  • [42] Hodgkin's variant of Richter transformation during ibrutinib therapy: A case report and review of the literature
    Afonso, Carolina
    Gomes, Marilia
    Pereira, Marta Isabel
    Faria, Carlos
    Pina, Raquel
    Saraiva, Tiago
    Geraldes, Catarina
    Carda, Jose Pedro
    CLINICAL CASE REPORTS, 2022, 10 (10):
  • [43] Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials
    Al-Sawaf, O.
    Robrecht, S.
    Bahlo, J.
    Fink, A. M.
    Cramer, P.
    Von Tresckow, J.
    Lange, E.
    Kiehl, M.
    Dreyling, M.
    Ritgen, M.
    Duerig, J.
    Tausch, E.
    Schneider, C.
    Stilgenbauer, S.
    Wendtner, C. M.
    Fischer, K.
    Goede, V
    Hallek, M.
    Eichhorst, B.
    LEUKEMIA, 2021, 35 (01) : 169 - 176
  • [44] Acalabrutinib, venetoclax, and obinutuzumab in relapsed/refractory CLL: final efficacy and ctDNA analysis of the CLL2-BAAG trial
    Fuerstenau, Moritz
    Giza, Adam
    Weiss, Jonathan
    Kleinert, Fanni
    Robrecht, Sandra
    Franzen, Fabian
    Stumpf, Janina
    Langerbeins, Petra
    Al-Sawaf, Othman
    Simon, Florian
    Fink, Anna-Maria
    Schneider, Christof
    Tausch, Eugen
    Schetelig, Johannes
    Dreger, Peter
    Boettcher, Sebastian
    Fischer, Kirsten
    Kreuzer, Karl-Anton
    Ritgen, Matthias
    Schilhabel, Anke
    Brueggemann, Monika
    Stilgenbauer, Stephan
    Eichhorst, Barbara
    Hallek, Michael
    Cramer, Paula
    BLOOD, 2024, 144 (03) : 272 - 282
  • [45] Emerging Therapies for the Management of Richter Transformation
    Smyth, Elizabeth
    Eyre, Toby A.
    Cheah, Chan Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (02) : 395 - +
  • [46] Evaluation of the CLL-IPI in relapsed and refractory chronic lymphocytic leukemia in idelalisib phase-3 trials
    Soumerai, Jacob D.
    Ni, Ai
    Xing, Guan
    Huang, Julie
    Furman, Richard R.
    Jones, Jeffrey
    Sharman, Jeffrey P.
    Hallek, Michael
    Adewoye, Adeboye H.
    Dubowy, Ronald
    Dreiling, Lyndah
    Zelenetz, Andrew D.
    LEUKEMIA & LYMPHOMA, 2019, 60 (06) : 1438 - 1446
  • [47] NGS Analysis of Clonality and Minimal Residual Disease in a Patient with Concurrent Richter's Transformation and CLL/SLL
    Kadkol, Shrihari S.
    Bland, Joshua
    Kavanaugh, Ashley
    Ni, Hongyu
    Nehru, Vijeyaluxmi
    Peace, David
    CASE REPORTS IN HEMATOLOGY, 2021, 2021
  • [48] Unmask the genetic backbone of ibrutinib-relapsed chronic lymphocytic leukemia progression and Richter transformation
    Wang, Wei-Ge
    Zhou, Xiao-Yan
    Li, Xiao-Qiu
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (11)
  • [49] 2-[18F]-FDG PET/CT Semiquantitative and Radiomics Predictive Parameters of Richter's Transformation in CLL Patients
    Albano, Domenico
    Calabro, Anna
    Dondi, Francesco
    Bertagna, Francesco
    MEDICINA-LITHUANIA, 2024, 60 (02):
  • [50] Richter’s Transformation
    Audrey M. Sigmund
    Adam S. Kittai
    Current Oncology Reports, 2022, 24 : 1081 - 1090
12345